Skip to content

Author

Ahmet Oruç

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study

Background Pathological complete response (pCR) after neoadjuvant therapy (NAT) is associated with long-term outcomes in breast cancer (BC). The remnant cholesterol inflammatory index (RCII) integrates lipid-related and inflammatory components, but its role in pCR prediction remains unclear. Methods This multicenter re...

Galip Can Uyar, Kadriye Başkurt, Ahmet Oruç et al. · 0 citations
Open access Oct 2026

Prognostic Value of Systemic Inflammation Markers and Clinical Factors in Grade 4 Diffuse Glioma: A Multicenter Retrospective Real-World Study

Simple Summary Glioblastoma and other grade 4 diffuse gliomas are the most aggressive brain tumors in adults. Clinicians still have few simple tools to estimate prognosis for individual patients. In this study of 120 patients treated at four centers, we examined whether routine blood tests and basic clinical informatio...

Ece Ulukal Karancı, G. Emin, Ahmet Oruç et al. · 0 citations
Open access Aug 2026

Treatment Sequencing of CDK4/6 Inhibitors in Bone-Only Hormone Receptor-Positive Metastatic Breast Cancer: Multi-Center Real-World Data Revealing a Numerical Trend Favoring Later-Line Use

Real-world findings highlight the need for personalized treatment sequencing in HR+/HER2− MBC patients presenting with bone-only metastasis, and first-line use showed a trend toward longer PFS, while later-line use showed a numerical trend toward longer OS.

S. Yıldırım, Büşra Bülbül, Bekir Ucun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.